# Genecast Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genecast-biotechnology-co

- Industry: Biotechnology
- Headquarters: Wuxi, China
- Website: www.genecast.com.cn
- Total disclosed funding: $248M
- Latest round: Series E (Oct 26, 2020)
- Investors on record: 19

## About

Founded in 2014 and based in Beijing, China, Genecast Biotechnology Co., Ltd. operates as a biotechnology company that develops cancer diagnosis and therapy. It provides DNA testing and gene-based medicine guidance including circulating DNA extraction and diagnosis that can be applied to lung cancer, rectal cancer, esophageal cancer, etc.

## Funding rounds

- Series E, Oct 26, 2020, $150M — Taikang Asset Management, China International Capital Corporation, China Renaissance, MPC, CCB Private Equity Investment Management, Shanghai Chengzheng Yubian Technology Investment, GL Ventures, Skycus Capital, China Structural Reform Fund Co., Ltd., Shanghai Shunheng Assets Management
- Series D, Oct 30, 2019, $43M — China International Capital Corporation, Co-Win Ventures, MPC, Alwin Capital
- Series C, Feb 11, 2018, $33M — Cowin Capital, MPC, Loyal Valley Capital, Alwin Capital
- Series B, Feb 10, 2017, $19M — Green Marine Capital, Co-Win Ventures, THG Ventures, Loyal Valley Capital, Yahui Precise Medical Care Fund
- Series A, Jan 29, 2016, $4M — Zehou Capital, Co-Win Ventures, Beijing Yifuze Investment Holdings
- Angel, Feb 28, 2015, $0.4M — Co-Win Ventures

## Investors

- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Angel, Series A, Series B, Series D
- Zehou Capital (https://capitalatlas.ai/funds/zehou-capital) — Series A
- Beijing Yifuze Investment Holdings — Series A
- Green Marine Capital (https://capitalatlas.ai/funds/green-marine-capital) — Series B
- THG Ventures (https://capitalatlas.ai/funds/thg-ventures) — Series B
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series B, Series C
- Yahui Precise Medical Care Fund — Series B
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series C
- MPC — Series C, Series D, Series E
- Alwin Capital — Series C, Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D, Series E
- Taikang Asset Management — Series E
- China Renaissance (https://capitalatlas.ai/funds/china-renaissance) — Series E
- CCB Private Equity Investment Management (https://capitalatlas.ai/funds/ccb-private-equity-investment-management) — Series E
- Shanghai Chengzheng Yubian Technology Investment — Series E
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series E
- Skycus Capital (https://capitalatlas.ai/funds/skycus-capital) — Series E
- China Structural Reform Fund Co., Ltd. — Series E
- Shanghai Shunheng Assets Management — Series E